Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria

Journal of Hypertension

Volumn 28, Issue 8, 2010, Pages 1655-1665

  Huang, Po Hsun ^a,c   Huang, Shao Sung ^a,c   Chen, Yung Hsiang ^d   Lin, Chih Pei ^b,c   Chiang, Kuang Hsing ^a,c   Chen, Jia Shiong ^c   Tsai, Hsiao Ya ^c   Lin, Feng Yen ^e   Chen, Jaw Wen ^a,b,c   Lin, Shing Jong ^a,b,c  

^a Division of Cardiology   (Australia)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

endothelial progenitor cell; hypertension; microalbuminuria

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIBODY; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROGEN PEROXIDE; LIPOCORTIN 5; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VASCULOTROPIN RECEPTOR 2;

ADULT; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CELL AGING; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; MICROALBUMINURIA; MONONUCLEAR CELL; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; URINARY EXCRETION;

EID: 77954951294     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833a4d0a     Document Type: Article

References (37)

1. Yudkin JS, Forrest RD, Jackson C. Microalbuminuria as predictor of vascular disease in nondiabetic subjects. Lancet 1988; 2:530-533.
2. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286:421-426.
3. Pontremoli R, Leoncini G, Ravera M, Viazzi F, Vettoretti S, Ratto E, et al. Microalbuminuria, cardiovascular, and renal risk in primary hypertension. J Am Soc Nephrol 2002; 13:169-172.
4. Pontremoli R, Ravera M, Bezante GP, Viazzi F, Nicolella C, Berruti V, et al. Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 1999; 17:993-1000.
5. Leoncini G, Sacchi G, Ravera M, Viazzi F, Ratto E, Vettoretti S, et al. Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. J Hum Hypertens 2002; 16:399-404. (Pubitemid 34685587)
6. Viazzi F, Leoncini G, Ratto E, Vaccaro V, Tomolillo C, Falqui V, et al. Microalbuminuria, blood pressure load, and systemic vascular permeability in primary hypertension. Am J Hypertens 2006; 19:1183-1189.
7. Asselbergs FW, de Boer RA, Diercks GF, Langeveld B, Tio RA,deJong PE, et al. Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria? Int J Cardiol 2004; 93:211-215.
8. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23:168-175.
9. Huang PH, Leu HB, Chen JW, Wu TC, Lu TM, Yu-An Ding P, et al. Decreased heparin cofactor II activity is associated with impaired endothelial function determined by brachial ultrasonography and predicts cardiovascular events. Int J Cardiol 2007; 114:152-158.
10. Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004; 9:1118-1135.
11. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Soderland C, Ahn YS. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol 2003; 123:896-902.
12. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101:841-843.
13. Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G. Circulating CD31\+/annexin V\+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26:112-116. (Pubitemid 43732236)
14. Pirro M, Schillaci G, Paltriccia R, Bagaglia F, Menecali C, Mannarino MR, et al. Increased ratio of CD31\+/CD42-microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006; 26:2530-2535.
15. Amabile N, Gué rin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16:3381-3388.
16. Werner N, Priller J, Laufs U, Endres M, Böhm M, Dirnagl U, et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002; 22:1567-1572.
17. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348:593-600.
18. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353:999-1007. (Pubitemid 41262334)
19. Huang PH, Leu HB, Chen JW, Wu TC, Ding YA, Lin SJ. Comparison of endothelial vasodilator function, inflammatory markers and N-terminal-pro-brain natriuretic peptide in patients with or without chronotropic incompetence to exercise test. Heart 2006; 92:609-614.
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
21. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89:1-7.
22. Huang PH, Chen YH, Chen JW, Wu TC, Chen YL, Lin SJ. Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 2007; 93:1064-1070.
23. Chen YH, Lin SJ, Lin FY, Wu TC, Tsao CR, Huang PH, et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007; 56:1559-1568.
24. Huang PH, Chen YH, Wang CH, Chen JS, Tsai HY, Lin FY, et al. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2009; 29:1179-1184.
25. Brunt KR, Fenrich KK, Kiani G, Tse MY, Pang SC, Ward CA, et al. Protection of human vascular smooth muscle cells from H2O2-induced apoptosis through functional codependence between HO-1 and AKT. Arterioscler Thromb Vasc Biol 2006; 26:2027-2034.
26. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, et al. Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol 2005; 16:180-188.
27. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M, et al. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002; 39:445-459. (Pubitemid 34194620)
28. Pedrinelli R, Dell'Omo G, Di Bello V, Pontremoli R, Mariani M. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens 2002; 16:79-89. (Pubitemid 34182916)
29. Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004; 17:986-993.
30. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32:219-226.
31. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndrome. N Engl J Med 1992; 326:310-318.
32. Huang PH, Chen JW, Wu TC, Ding YA, Lin SJ. Combined use of endothelial function and high-sensitive C-reactive protein in predicting cardiovascular events in patients with suspected coronary artery disease. Clin Cardiol 2007; 30:135-140.
33. Greer IA. Endothelial cell microparticles and antiphospholipid syndrome: pathologic explanations and diagnostic opportunities. Thromb Haemost 2004; 91:636-638.
34. Bernal-Mizrachi L, Jy W, Fierro C, Macdonough R, Velazques HA, Purow J, et al. Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol 2004; 97:439-446.
35. Witte EC, Lambers Heerspink HJ, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort R. First morning voids are more reliable than spot urine samples to assess microalbuminuria. J Am Soc Nephrol 2009; 20:436-443.
36. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104:2649-2652.
37. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59:277-287.